tiprankstipranks
Trending News
More News >
AARTI Industries Ltd (IN:AARTIIND)
:AARTIIND
India Market

AARTI Industries Ltd (AARTIIND) AI Stock Analysis

Compare
6 Followers

Top Page

IN:AARTIIND

AARTI Industries Ltd

(AARTIIND)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
₹414.00
▲(12.07% Upside)
AARTI Industries Ltd has a solid financial performance with strong revenue growth and cash flow management, but faces challenges with profitability and leverage. The technical indicators suggest a neutral trend with weak momentum. The high P/E ratio and low dividend yield indicate potential overvaluation and limited income potential. These factors combine to give the stock a moderate score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion.
Cash Flow Management
Strong cash flow management enhances financial stability and provides funds for reinvestment and debt reduction, supporting sustainable growth.
Operational Efficiency
Improved cost management and operational efficiency strengthen profitability, allowing the company to better withstand market fluctuations.
Negative Factors
Declining Profit Margins
Decreasing profit margins may signal challenges in cost control or pricing power, potentially impacting long-term profitability.
Rising Leverage
Higher leverage increases financial risk and can limit flexibility in funding operations or growth initiatives, affecting long-term stability.
Declining ROE
A declining ROE suggests reduced efficiency in using equity capital to generate profits, potentially impacting investor confidence and growth prospects.

AARTI Industries Ltd (AARTIIND) vs. iShares MSCI India ETF (INDA)

AARTI Industries Ltd Business Overview & Revenue Model

Company DescriptionAarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.
How the Company Makes MoneyAARTI Industries generates revenue through the production and sale of a wide array of chemical products and pharmaceutical ingredients. The company’s revenue model is built on several key streams, including the sale of specialty chemicals, which cater to various sectors like agrochemicals and plastics, and APIs that serve the pharmaceutical industry. Additionally, AARTIIND benefits from long-term supply contracts with both domestic and international clients, which provide stable revenue inflows. The company has also established strategic partnerships and collaborations that enhance its product offerings and market reach, contributing to its overall earnings. Furthermore, AARTIIND’s focus on research and development enables it to innovate and expand its product portfolio, which is crucial for maintaining competitive advantage and capturing new market opportunities.

AARTI Industries Ltd Financial Statement Overview

Summary
AARTI Industries Ltd shows a positive financial trajectory with notable revenue growth and improved cash flow generation. However, the decline in net profit margin and return on equity indicate areas of concern that need addressing. The increase in leverage heightens financial risk, though the company's solid equity base provides a cushion. Overall, the financials reflect a company with strong operational performance and cash management, but with potential risks associated with profitability and leverage.
Income Statement
75
Positive
AARTI Industries Ltd has demonstrated consistent revenue growth from 2020 to 2025, with a noticeable increase from 63,710 million to 72,710 million in 2025, translating to a revenue growth rate of approximately 14.11% from the previous year. However, the gross profit margin has decreased from 23.9% in 2020 to 36.0% in 2025, indicating improved efficiency in cost management. The net profit margin has decreased from 13.1% to 4.55%, suggesting challenges in maintaining bottom-line profitability. The EBIT margin is stable at 7.79%, while the EBITDA margin is 13.97%, reflecting solid operational performance.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has increased from 0.71 in 2020 to 0.69 in 2025, indicating a rise in leverage. Despite this, the equity ratio remains healthy at approximately 50.4%, showing a strong equity base. Return on Equity (ROE) has decreased from 18.0% to 5.9%, pointing to declining efficiency in generating profits from shareholders' equity. While the balance sheet reflects a solid equity foundation, the increase in leverage could pose potential risks if not managed effectively.
Cash Flow
80
Positive
AARTI Industries has improved its free cash flow from negative in prior years to 12,420 million in 2025, demonstrating a significant turnaround. The operating cash flow to net income ratio is 3.75, indicating strong cash generation from operations. The free cash flow to net income ratio is 3.75 as well, underscoring efficient conversion of net income into free cash flow. The positive trend in cash flow metrics suggests robust cash management and operational efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue70.91B72.71B63.71B65.41B60.11B44.64B
Gross Profit24.69B26.16B8.86B17.98B18.12B10.53B
EBITDA9.21B10.16B9.78B10.28B16.87B9.73B
Net Income2.37B3.31B4.16B5.45B11.86B5.23B
Balance Sheet
Total Assets0.00111.14B96.16B85.81B78.51B76.42B
Cash, Cash Equivalents and Short-Term Investments2.95B3.11B1.28B1.99B1.71B4.10B
Total Debt0.0038.47B32.42B29.07B25.87B28.62B
Total Liabilities-56.05B55.09B43.25B36.60B33.33B41.27B
Stockholders Equity56.05B56.05B52.90B49.20B45.17B35.03B
Cash Flow
Free Cash Flow0.00-1.44B-1.24B-75.60M-6.47B-4.42B
Operating Cash Flow0.0012.42B12.04B13.19B5.19B8.73B
Investing Cash Flow0.00-13.98B-13.69B-13.30B-11.69B-13.22B
Financing Cash Flow0.00-730.00M4.20B382.10M4.12B6.14B

AARTI Industries Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price369.40
Price Trends
50DMA
378.01
Negative
100DMA
382.71
Negative
200DMA
409.35
Negative
Market Momentum
MACD
-4.30
Negative
RSI
48.20
Neutral
STOCH
57.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AARTIIND, the sentiment is Negative. The current price of 369.4 is above the 20-day moving average (MA) of 368.99, below the 50-day MA of 378.01, and below the 200-day MA of 409.35, indicating a neutral trend. The MACD of -4.30 indicates Negative momentum. The RSI at 48.20 is Neutral, neither overbought nor oversold. The STOCH value of 57.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:AARTIIND.

AARTI Industries Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹93.72B38.440.32%16.07%-6.83%
64
Neutral
₹120.53B45.180.16%24.25%96.45%
62
Neutral
₹133.94B46.020.27%8.26%-34.62%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹82.26B45.150.62%3.95%8.28%
61
Neutral
₹193.72B31.812.90%8.92%5.06%
52
Neutral
₹227.29B42.770.45%-7.50%-37.67%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:AARTIIND
AARTI Industries Ltd
369.40
-39.16
-9.58%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,608.35
-237.90
-12.89%
IN:BAYERCROP
Bayer Cropscience India Limited
4,310.35
-1,301.24
-23.19%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,666.40
-917.01
-35.50%
IN:PRIVISCL
Privi Speciality Chemicals Limited
3,085.65
1,341.54
76.92%
IN:VESUVIUS
Vesuvius India Ltd
461.75
-14.93
-3.13%

AARTI Industries Ltd Corporate Events

Aarti Industries to Engage with Investors at Avendus Conference
Nov 10, 2025

Aarti Industries Limited announced its participation in the Avendus Spark INDX: Annual Investor Conference, scheduled for November 18, 2025, at the Grand Hyatt, Kalina, Mumbai. This event, which will include a mix of one-on-one and group meetings, is part of the company’s ongoing efforts to engage with analysts and investors, potentially impacting its market visibility and investor relations.

Aarti Industries Releases Q2 FY26 Financial Results
Nov 6, 2025

Aarti Industries Ltd has released its Investor Presentation detailing the unaudited financial results for the second quarter of the fiscal year 2026. This announcement provides stakeholders with insights into the company’s financial performance and strategic direction, highlighting its commitment to maintaining excellence and exploring future growth opportunities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025